Guest guest Posted December 2, 2008 Report Share Posted December 2, 2008 Update on Front-Line Therapy of CML With Imatinib and Results With Second-Generation Tyrosine Kinase Inhibitors presented by Dr. O'Brien about Iris trials. Slides with Audio. http://www.medscape.com/viewarticle/581991 Blessings, Lottie Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.